Skip to content
Home/Companies/Healthcare/PronoKal Group

PronoKal Group

Healthcare·Spain·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns PronoKal Group?

PronoKal Group is a Spanish Healthcare company, currently owned by DUBAG Group since 2025. It changed hands in 2022, when Abac Capital sold.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
DUBAG Group
Most recent investor
DUBAG Group
Lenbach Equity Opportunities III · 2024 · Turnaround
2 ownership periods · full history below

Key facts

HQSpain
SectorHealthcare
StatusActive

Ownership history

2 ownership periods

Active
Currently held by DUBAG Group since 2025.
Abac Capital
Abac CapitalExited 2022
2017 · 2022(5yr) · Abac Solutions Fund I · 2016 · Buyout
Trade Sale · to Nestle Health Science

Abac Capital sold PronoKal Group to Nestle Health Science in 2022 after 5 years.

DUBAG Group
2025 · present(1yr) · Lenbach Equity Opportunities III · 2024 · Turnaround

Questions

Who owns PronoKal Group?

PronoKal Group is currently owned by DUBAG Group, through Lenbach Equity Opportunities III, since 2025.

When did DUBAG Group acquire PronoKal Group?

DUBAG Group acquired PronoKal Group in 2025.

Who did PronoKal Group sell to?

Abac Capital sold PronoKal Group to Nestle Health Science in 2022 (Trade Sale).

Who has owned PronoKal Group over time?

PronoKal Group has been through 2 private-equity ownership periods: Abac Capital · via Abac Solutions Fund I · 2017–2022 · sold to Nestle Health Science · (Trade Sale); DUBAG Group · via Lenbach Equity Opportunities III · since 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue